EPAS1
From Wikipedia, the free encyclopedia
Endothelial PAS domain protein 1
|
||||||||||||||
PDB rendering based on 1p97. | ||||||||||||||
Available structures: 1p97, 2a24 | ||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | EPAS1; HIF2A; HLF; MOP2; PASD2 | |||||||||||||
External IDs | OMIM: 603349 MGI: 109169 HomoloGene: 1095 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 2034 | 13819 | ||||||||||||
Ensembl | ENSG00000116016 | ENSMUSG00000024140 | ||||||||||||
Uniprot | Q99814 | Q6PEU2 | ||||||||||||
Refseq | NM_001430 (mRNA) NP_001421 (protein) |
XM_986887 (mRNA) XP_991981 (protein) |
||||||||||||
Location | Chr 2: 46.38 - 46.47 Mb | Chr 17: 86.66 - 86.74 Mb | ||||||||||||
Pubmed search | [1] | [2] |
Endothelial PAS domain protein 1, also known as EPAS1, is a human gene.[1]
[edit] References
[edit] Further reading
- Brahimi-Horn MC, Pouysségur J (2005). "The hypoxia-inducible factor and tumor progression along the angiogenic pathway.". Int. Rev. Cytol. 242: 157–213. doi: . PMID 15598469.
- Haase VH (2006). "Hypoxia-inducible factors in the kidney.". Am. J. Physiol. Renal Physiol. 291 (2): F271–81. doi: . PMID 16554418.
- Andersson B, Wentland MA, Ricafrente JY, et al. (1996). "A "double adaptor" method for improved shotgun library construction.". Anal. Biochem. 236 (1): 107–13. doi: . PMID 8619474.
- Tian H, McKnight SL, Russell DW (1997). "Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells.". Genes Dev. 11 (1): 72–82. PMID 9000051.
- Hogenesch JB, Chan WK, Jackiw VH, et al. (1997). "Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway.". J. Biol. Chem. 272 (13): 8581–93. PMID 9079689.
- Yu W, Andersson B, Worley KC, et al. (1997). "Large-scale concatenation cDNA sequencing.". Genome Res. 7 (4): 353–8. PMID 9110174.
- Ema M, Taya S, Yokotani N, et al. (1997). "A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development.". Proc. Natl. Acad. Sci. U.S.A. 94 (9): 4273–8. PMID 9113979.
- Hogenesch JB, Gu YZ, Jain S, Bradfield CA (1998). "The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors.". Proc. Natl. Acad. Sci. U.S.A. 95 (10): 5474–9. PMID 9576906.
- Takahata S, Sogawa K, Kobayashi A, et al. (1998). "Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1a, HLF, and clock.". Biochem. Biophys. Res. Commun. 248 (3): 789–94. doi: . PMID 9704006.
- Ema M, Hirota K, Mimura J, et al. (1999). "Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300.". EMBO J. 18 (7): 1905–14. doi: . PMID 10202154.
- Cockman ME, Masson N, Mole DR, et al. (2000). "Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.". J. Biol. Chem. 275 (33): 25733–41. doi: . PMID 10823831.
- Maemura K, de la Monte SM, Chin MT, et al. (2001). "CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression.". J. Biol. Chem. 275 (47): 36847–51. doi: . PMID 11018023.
- Luo JC, Shibuya M (2001). "A variant of nuclear localization signal of bipartite-type is required for the nuclear translocation of hypoxia inducible factors (1alpha, 2alpha and 3alpha).". Oncogene 20 (12): 1435–44. doi: . PMID 11313887.
- Woods SL, Whitelaw ML (2002). "Differential activities of murine single minded 1 (SIM1) and SIM2 on a hypoxic response element. Cross-talk between basic helix-loop-helix/per-Arnt-Sim homology transcription factors.". J. Biol. Chem. 277 (12): 10236–43. doi: . PMID 11782478.
- Lando D, Peet DJ, Whelan DA, et al. (2002). "Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch.". Science 295 (5556): 858–61. doi: . PMID 11823643.
- Mole DR, Pugh CW, Ratcliffe PJ, Maxwell PH (2002). "Regulation of the HIF pathway: enzymatic hydroxylation of a conserved prolyl residue in hypoxia-inducible factor alpha subunits governs capture by the pVHL E3 ubiquitin ligase complex.". Adv. Enzyme Regul. 42: 333–47. PMID 12123724.
- Sivridis E, Giatromanolaki A, Gatter KC, et al. (2002). "Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.". Cancer 95 (5): 1055–63. doi: . PMID 12209691.
- Elvert G, Kappel A, Heidenreich R, et al. (2003). "Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha ) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1).". J. Biol. Chem. 278 (9): 7520–30. doi: . PMID 12464608.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Sang N, Stiehl DP, Bohensky J, et al. (2003). "MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300.". J. Biol. Chem. 278 (16): 14013–9. doi: . PMID 12588875.
[edit] External links
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
|